Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.2K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.2K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

979
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
979
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

921
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
921
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

837
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
837

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Violence during pregnancy amplifies fear of childbirth: A nationwide cohort study in Finland.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

Associations between maternal prepregnancy body mass index and maternal and cord blood metabolome.

Journal of the Endocrine Society·2026
Same author

Impact of Preeclampsia Duration on Long-Term Cardiovascular Disease Risk.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Basic reproduction number varies markedly between closely related pandemic Escherichia coli clones.

Nature communications·2025
Same author

Computational modeling enables individual assessment of postprandial glucose and insulin responses after bariatric surgery.

Communications medicine·2025
Same author

The climate impacts of healthcare digitalization: A scoping review.

Digital health·2025
Same journal

Stakeholder Experiences With the Pneumococcal Conjugate Vaccine Chatbot as a Complementary Capacity-Building Tool for Frontline Health Workers in India: Qualitative Study.

JMIR formative research·2026
Same journal

Acceptability and Perceived Usefulness of a Digital Gambling Harm Minimisation Tool: A Cross-Sectional Study.

JMIR formative research·2026
Same journal

Knowledge Graphs Based on Meta-Analysis Papers Improve the Quality of Case Formulation: Mixed Methods Design.

JMIR formative research·2026
Same journal

Expedited Transition to Digital Delivery of Recovery Support Services Due to the COVID-19 Pandemic: Mixed Methods Needs Assessment.

JMIR formative research·2026
Same journal

Impact of an mHealth App on Digital Transformation: Randomized Clinical Trial on Strengthening Digital Skills in Older Women.

JMIR formative research·2026
Same journal

Emotion Classification in Japanese Cancer Survivor Interview Narratives Using Sentiment Polarity and Plutchik Emotion Frameworks: Model Development and Evaluation Study.

JMIR formative research·2026
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Personalized Glucose Management With AI: Pilot Study Using a Multiarmed Bandit Approach.

Shinji Hotta1,2, Mikko Kytö3,4, Saila Koivusalo5

  • 1Fujitsu Limited, 4-1-1 Kamikodanaka, Nakahara-ku, Kawasaki, Kanagawa, 211-8588, Japan, 81 44 777 1111.

JMIR Formative Research
|March 19, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a new method for personalized mobile app recommendations to optimize blood sugar levels by directly influencing dietary and exercise behaviors. The approach showed a 23% improvement in glucose control and adherence in a real-world test.

Keywords:
diabetesdietary and exercise recommendationglucose managementmobile interventionmultiarmed banditpersonalization

More Related Videos

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.6K

Related Experiment Videos

Last Updated: Mar 21, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.6K

Area of Science:

  • Digital Health
  • Behavioral Science
  • Metabolic Health

Background:

  • Mobile apps offer personalized behavioral recommendations for chronic disease prevention, notably diabetes.
  • Current reinforcement learning approaches optimize recommendations but often neglect clinical outcomes.
  • Focusing solely on behavior change overlooks critical clinical results.

Purpose of the Study:

  • To propose an online planning method for dietary and exercise recommendations.
  • To optimize postprandial glucose levels directly through behavioral modifications.
  • To enhance clinical outcomes by linking behavioral changes to glucose response.

Main Methods:

  • A multiarmed bandit approach with a two-stage reward prediction model was developed.
  • Actions involved combinations of carbohydrate intake and postprandial walking duration.
  • Rewards were defined as reductions in postprandial glucose levels, incorporating predicted behavioral and glycemic responses.

Main Results:

  • Simulation experiments demonstrated significant improvements in postprandial glucose levels compared to randomized policies.
  • A small-scale real-world experiment with 6 participants showed a 23% average improvement in glucose response.
  • High behavioral adherence to carbohydrate intake and walking recommendations was observed.

Conclusions:

  • The proposed method shows preliminary effectiveness in improving postprandial glucose control through personalized recommendations.
  • Both simulation and real-world experiments support the method's potential.
  • Further longitudinal studies in diabetic patients are necessary for validation and generalization.